CCCC Research and Charts

CCCC - C4 Therapeutics Inc Ordinary Shares (Healthcare: Biotechnology)

Projected Earnings Date: 2024-08-05 (Delayed quote data 2025-06-30)

Last 1.43	Change ⇑ +0.03 (+2.14%)	Volume 677,845
	Open 1.42	High 1.48	Low 1.40

8EMA (Daily) 1.48	40EMA (Daily) 1.53	50EMA (Daily) 1.58	STO (Daily) 31.303	MACD Hist (Daily) -0.017
8EMA (Weekly) 1.495	40EMA (Weekly) 2.80	50EMA (Weekly) 3.14	STO (Weekly) 39.798	MACD Hist (Weekly) 0.181


Company Profile
C4 Therapeutics Inc is a bio-pharmaceutical company. The company is focused on harnessing the body's natural regulation of protein levels to develop novel therapeutic candidates to eliminate disease-causing proteins for the treatment of cancer, neurodegenerative conditions and other diseases.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.